; (II) such ingredient is supplied by a single manufacturing facility; (III) such ingredient is necessary for the manufacture of medical countermeasures or medicines deemed essential from a public health perspective; (IV) the manufacture of such ingredient would improve the ability of other entities to enter the market for the manufacture of applicable drugs or otherwise expand the manufacture of applicable drugs; or (V) the manufacture of such ingredient is necessary for, or would improve the ability of, the Office to carry out its duties under this section. (ii) Price determinations In determining what price at which to sell an active pharmaceutical ingredient under clause (i), the Office shall consider the cost to manufacture the ingredient, the administrative costs of the Office with respect to the ingredient, and the impact of such price on market competition for the ingredient. (F) Purchase requirements Notwithstanding applicable laws relating to the procurement of prescription drugs, the Office shall establish minimum purchase requirements for the Department of Veterans Affairs, the Department of Defense, the Public Health Service, and the Coast Guard to purchase drugs manufactured by or as a result of the Office. (G) Limitation on undue influence The Food and Drug Administration shall consider an application submitted by the Office under subparagraph (A)(i) in the same manner in which the Administration considers applications submitted by other manufacturers. Nothing in this paragraph shall be construed to require the Food and Drug Administration to give special deference to any determination made, or application submitted, by the Office. (5) Priority manufacturing The Office shall prioritize the manufacturing of those applicable drugs that would have the greatest impact on— (A) lowering drug costs to patients; (B) increasing competition and addressing drug shortages in the pharmaceutical market; (C) improving public health; (D) addressing health disparities